June 3, 2020         
Digital US Launches With a Roadmap to Achieve Digital Resilience for American Workers   •   NortonLifeLock Announces New Cyber Safety Protection Offer for AARP Members   •   International E-Commerce Data Shows Surge in First-Time Online Shoppers   •   BET Unveils Series of Programming Addressing Systemic Racism, the Violence Faced by Black People in America and the Solutions to   •   Bank of America Announces $1 Billion/4-Year Commitment to Support Economic Opportunity Initiatives   •   Government of Canada announces interest relief for First Nations through the First Nations Finance Authority   •   Roy Maas Youth Alternatives (RMYA) Achieves National COA Accreditation   •   Statement Against Racism and Violence in the United States   •   $15,000 in Scholarships Aims to Encourage Minorities and Women to Pursue a Career in Financial Planning   •   The Only Task Management Platform You Need Launched to Help Remote Workers, Freelancers, Small Business   •   Statement From March Of Dimes In Response To The Death Of George Floyd   •   Science-Based Assessments and Action Strategies Help Voting Jurisdictions Conduct Healthy Elections   •   Memorial Reefs International Announces New Jersey Location   •   Word of Faith International Christian Center: Arrest Officers Who Killed George Floyd Now!   •   Statement by Donnell Williams President, National Association of Real Estate Brokers on the Current State of Unrest within the U   •   MONAT Global Extends Exclusive Mentoring Program With Leadership Coach John C. Maxwell   •   Statement - Commemoration of the Fifth anniversary of the truth and reconciliation Commission Calls to action   •   Turning the Tassels on the Pandemic: Insight School of Indiana Celebrates 2020 Graduates with Online Commencement Ceremony   •   Kering And Its Brands Stand In Solidarity Against Racism   •   American Dental Education Association (ADEA) Statement on National Crisis
Bookmark and Share

The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028

The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028

PR Newswire

NEW YORK, April 6, 2020 /PRNewswire/ --



KEY FINDINGS

The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028. The factors that offer lucrative growth opportunities include a surge in the geriatric population all over the world, an increase in the incidences of obesity, a rise in awareness related to early screening and treatment of rheumatoid arthritis.







Read the full report: https://www.reportlinker.com/p05880965/?utm_source=PRN







MARKET INSIGHTS

Rheumatoid arthritis is a chronic inflammatory medical condition, which causes painful and swollen joints in patients.The drugs used for the treatment of rheumatoid arthritis are called anti-rheumatics.



In addition, different types of drugs are used to treat this condition.For example, disease-modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs, corticosteroids, and others.



A rapid increase in the geriatric population is one of the significant factors driving the market. The global geriatric population has risen considerably and is vulnerable to rheumatoid arthritis.

Patent expirations are one of the factors restricting the market growth.Patent expirations result in the entry of low-priced generics, which constrains its growth.



Moreover, the market is flooded with biologics, which are considered important for the treatment of rheumatoid arthritis.Some are on the verge of patent expiration, and some are no longer exclusive.



The patent expiration of popular drugs results in the availability of generics, which are low-prices and impact the revenue generated in the market and hinder the market growth.The competitive rivalry is high in the market, owing to the presence of similar products offered by various players.



Disease-modifying anti-rheumatics drugs category in the drug class segment garnered the largest market share in 2019.



REGIONAL INSIGHTS

The global anti-rheumatics market is analyzed geographically on the basis of the markets situated across the regions of North America, Europe, Asia Pacific, and the Rest of the World.As of 2019, the region of North America holds the largest market share in terms of revenue.



This is attributed to the rising geriatric population.



COMPETITIVE INSIGHTS

The market boasts of many prominent players registering their presence in the global market.Some of the major players functioning in the market are Abbott Laboratories, Lupin Ltd, F.



Hoffmann-La Roche Ltd, Johnson & Johnson, Novartis International AG, etc.



Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation cater to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



Companies mentioned

1. ABBOTT LABORATORIES

2. ABBVIE INC

3. AMGEN INC

4. BECTON, DICKINSON & COMPANY (BD)

5. BIO-RAD LABORATORIES INC

6. BRISTOL-MYERS SQUIBB COMPANY

7. ELI LILLY & COMPANY

8. LUPIN LIMITED

9. F. HOFFMANN-LA ROCHE

10. JOHNSON & JOHNSON

11. MERCK & CO INC

12. NOVARTIS AG

13. PERKINELMER

14. PFIZER INC

15. UCB



Read the full report: https://www.reportlinker.com/p05880965/?utm_source=PRN



About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.



__________________________

Contact Clare: clare@reportlinker.com

US: (339)-368-6001

Intl: +1 339-368-6001

 

Cision View original content:http://www.prnewswire.com/news-releases/the-global-anti-rheumatics-market-is-anticipated-to-record-a-cagr-of-2-32-during-the-projected-period-of-2020-2028--301035749.html

SOURCE Reportlinker



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News